“Rising adoption of minimally invasive technology is driving the growth of cardiomyopathy market.”
Orion Market Research (OMR), recently published a market research report on the global cardiomyopathy market. According to the OMR analysis, the global cardiomyopathy market is growing significantly during the forecast period (2018-2023). The global cardiomyopathy market has witnessed a significant growth due to rise in incidences of congestive heart failure, coronary heart disease, and heart attack. The global cardiomyopathy market is segmented on the basis of type, diagnosis test, treatment and geography. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, company profiling, market segmentation, geographical analysis, analyst insights.
“The cause of the cardiomyopathy is unknown. Contributing factors for acquired cardiomyopathy include long-term high blood pressure, heart tissue damage from a heart attack, chronic rapid heart rate, heart valve problems, metabolic disorders, such as obesity, thyroid disease or diabetes and nutritional deficiencies of essential vitamins or minerals, such as thiamin (vitamin B-1).
The doctor diagnose cardiomyopathy based on patient’s medical and family histories. Often, a cardiologist or pediatric cardiologist diagnoses and treats cardiomyopathy. These doctors specialize in heart diseases. Diagnostic test includes chest x-ray, echocardiogram, electrocardiogram (ECG), treadmill stress test, cardiac catheterization, cardiac MRI, cardiac CT scan, blood tests and genetic testing or screening. After the diagnosis of cardiomyopathy, medical procedures are performed. The result of diagnostic test may be used to prepare for surgery, if surgery is planned. These procedures may include coronary angiography, cardiac catheterization, or myocardial biopsy.
The market on the basis of geography is divided among four major regions – North America, APAC, Europe, and Rest of the world. North America is the leading market. The market is expected to grow considerably during the forecast period. North American market is driven due to growing geriatric population and increasing heart diseases. Asia Pacific market is expected to have the highest CAGR amongst all regions for the forecast period of 2018-2023. The rapidly developing healthcare infrastructure and growing demand for minimally invasive surgery in the region are supporting growth of this region.
THE REPORT COVERS:
Comprehensive research methodology of global cardiomyopathy market
In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global cardiomyopathy market
Insights about market determinants which are stimulating the global cardiomyopathy market
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players
Browse full report at: Global Cardiomyopathy Market Research
For related reports at: Medical Devices Industry Research